AstraZeneca looking outside for drugs

AstraZeneca has trailed rivals such as Novartis and Pfizer in its willingness to purchase promising drugs that were discovered outside their own laboratories, and the drugmaker now is playing catch-up. Over the past few months AstraZeneca has signed several deals totaling up to $1.6 billion to license drug candidates and may be considering additional alliances.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC